Cancer Cell Fusion: Mechanisms Slowly Unravel
AbstractAlthough molecular mechanisms and signaling pathways driving invasion and metastasis have been studied for many years, the origin of the population of metastatic cells within the primary tumor is still not well understood. About a century ago, Aichel proposed that cancer cell fusion was a mechanism of cancer metastasis. This hypothesis gained some support over the years, and recently became the focus of many studies that revealed increasing evidence pointing to the possibility that cancer cell fusion probably gives rise to the metastatic phenotype by generating widespread genetic and epigenetic diversity, leading to the emergence of critical populations needed to evolve resistance to the treatment and development of metastasis. In this review, we will discuss the clinical relevance of cancer cell fusion, describe emerging mechanisms of cancer cell fusion, address why inhibiting cancer cell fusion could represent a critical line of attack to limit drug resistance and to prevent metastasis, and suggest one new modality for doing so. View Full-Text
Share & Cite This Article
Noubissi, F.K.; Ogle, B.M. Cancer Cell Fusion: Mechanisms Slowly Unravel. Int. J. Mol. Sci. 2016, 17, 1587.
Noubissi FK, Ogle BM. Cancer Cell Fusion: Mechanisms Slowly Unravel. International Journal of Molecular Sciences. 2016; 17(9):1587.Chicago/Turabian Style
Noubissi, Felicite K.; Ogle, Brenda M. 2016. "Cancer Cell Fusion: Mechanisms Slowly Unravel." Int. J. Mol. Sci. 17, no. 9: 1587.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.